Verdad Advisers’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23,487
Closed -$1.01M – 279
2026
Q2
$1.01M Buy
23,487
+13,306
+131% +$496K 0.97% 26
2026
Q1
$410K Buy
+10,181
New +$439K 0.46% 78

Other funds holding VERA

Verdad Advisers's VERA Position: Q3 2026 in Review

Verdad Advisers sold out of Vera Therapeutics (VERA) in Q3 2026, closing a stake of 23,487 shares — an estimated $1.01M sold.

Verdad Advisers first reported a position in VERA in Q1 2026 and held it in 2 quarters. The position peaked at $1.01M in Q2 2026. 224 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Verdad Advisers reported no remaining Vera Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Verdad Advisers sold 23,487 Vera Therapeutics shares in Q3 2026, an estimated $1.01M.
  • Verdad Advisers first reported a position in Vera Therapeutics in Q1 2026 and held it in 2 quarters.
  • Verdad Advisers's Vera Therapeutics position peaked at $1.01M in Q2 2026.
  • 224 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Verdad Advisers's 13F filing for Q3 2026, filed 16 Nov 2026.